Evidence that the acute phase of ischemic preconditioning does not require signaling by the A2B adenosine receptor

Journal of Molecular and Cellular Cardiology

Volumn 49, Issue 5, 2010, Pages 886-893

  Maas, Jason E ^a   Wan, Tina C ^a   Figler, Robert A ^b   Gross, Garrett J ^a   Auchampach, John A ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b A Division of Clinical Data Inc   (United States)

Author keywords

Adenosine; Adenosine receptors; Ischemia reperfusion injury; Ischemic preconditioning; Myocardial infarction

Indexed keywords

ADENOSINE A2B RECEPTOR; ADENOSINE A2B RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR BLOCKING AGENT; ATL 801; BAY 60 6583; BETA GALACTOSIDASE; TROPONIN I; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; IN VIVO STUDY; ISCHEMIC PRECONDITIONING; ISOLATED HEART; KNOCKOUT GENE; MALE; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; REPORTER GENE; SIGNAL TRANSDUCTION;

AMINOPYRIDINES; ANIMALS; BLOOD PRESSURE; HEART FUNCTION TESTS; HEART RATE; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MICE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A2B; SIGNAL TRANSDUCTION;

MUS; RATTUS;

EID: 77957236611     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.08.015     Document Type: Article

References (29)

1. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986, 1124-1136.
2. Miura T., Goto M., Urabe K., Endoh A., Shimamoto K., Iimura O. Does myocardial stunning contribute to infarct size limitation by ischemic preconditioning?. Circulation 1991, 84:2504-2512.
3. Murry C.E., Richard V.J., Jennings R.B., Reimer K.A. Myocardial protection is lost before contractile function recovers from ischemic preconditioning. Am J Physiol 1991, 260:H796-H804.
4. Van Winkle D.M., Thornton J.D., Downey D.M., Downey J.M. The natural history of preconditioning: cardioprotection depends on the duration of transient ischemia and time to subsequent ischemia. Cor Art Dis 1991, 2:613-619.
5. Bolli R. The late phase of preconditioning. Circ Res 2000, 87:972-983.
6. Murry C.E., Richard V.J., Reimer K.A., Jennings R.B. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res 1990, 66:913-931.
7. Armstrong S.C., Hoover D.B., Shivell L.C., Ganote C.E. Preconditioning of isolated rabbit cardiomyocytes: no evident separation of induction, memory and protection. J Mol Cell Cardiol 1997, 29:2285-2298.
8. Harrison G.J., Willis R.J., Headrick J.P. Extracellular adenosine levels and cellular energy metabolism in ischemically preconditioned rat heart. Cardiovasc Res 1998, 40:74-87.
9. Cohen M.V., Downey J.M. Adenosine: trigger and mediator of cardioprotection. Basic Res Cardiol 2008, 103:203-215.
10. ATP channels, and ischemic preconditioning in dogs. Am J Physiol 1993, 264:H1327-H1336.
11. 1 adenosine receptor expression on protection with ischemic preconditioning. Am J Physiol Heart Circ Physiol 2006, 290:H1469-H1473.
12. 1 adenosine receptors in rabbit heart. Circulation 1991, 84:350-356.
13. Tsuchida A., Miura T., Miki T., Shimamoto K., Iimura O. Role of adenosine receptor activation in myocardial infarct size limitation by ischaemic preconditioning. Cardiovasc Res 1992, 26:456-461.
14. Belardinelli L., Shryock J.C., Song Y., Wang D., Srinivas M. Ionic basis of the electrophysiological actions of adenosine on cardiomyocytes. FASEB J 1995, 9:359-365.
15. Shryock J.C., Belardinelli L. Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology. Am J Cardiol 1997, 79:2-10.
16. 2B adenosine receptors. Circulation 2007, 115:1581-1590.
17. Eckle T., Kohler D., Lehmann R., El Kasmi K., Eltzschig H.K. Hypoxia-inducible factor-1 is central to cardioprotection: a new paradigm for ischemic preconditioning. Circulation 2008, 118:166-175.
18. Thornton J., Striplin S., Liu G.S., Swafford A., Stanley A.W., Van Winkle D.M., et al. Inhibition of protein synthesis does not block myocardial protection afforded by preconditioning. Am J Physiol 1990, 259:H1822-H1825.
19. 2B adenosine receptor protects against inflammation and excessive vascular adhesion. J Clin Invest 2006, 116:1913-1923.
20. 2B receptors ameliorates murine colitis. Br J Pharmacol 2008, 155:127-137.
21. 6-(2, 5-dichlorobenzyl)-3'-aminoadenosine-5'-N-methylcarboxamide] protects against myocardial ischemia/reperfusion injury via the sarcolemmal ATP-sensitive potassium channel. J Pharmacol Exp Ther 2008, 324:234-243.
22. 3 adenosine receptor. J Pharmacol Exp Ther 2006, 319:1200-1210.
23. Gross G.J., Gauthier K.M., Moore J., Campbell W.B., Falck J.R., Nithipatikom K. Evidence for role of epoxyeicosatrienoic acids in mediating ischemic preconditioning and postconditioning in dog. Am J Physiol Heart Circ Physiol 2009, 297:H47-H52.
24. Yang X., Cohen M.V., Downey J.M. Mechanism of cardioprotection by early ischemic preconditioning. Cardiovasc Drugs Ther 2010, 24:225-234. 10.1007/s10557-010-6236-x.
25. Goto M., Cohen M.V., van Wylen D.G., Downey J.M. Attenuated purine production during subsequent ischemia in preconditioned rabbit myocardium is unrelated to the mechanism of protection. J Mol Cell Cardiol 1996, 28:447-454.
26. Schulz R., Post H., Vahlhaus C., Heusch G. Ischemic preconditioning in pigs: a graded phenomenon: its relation to adenosine and bradykinin. Circulation 1998, 98:1022-1029.
27. 2b-dependent signaling during early reperfusion. J Mol Cell Cardiol 2007, 43:262-271.
28. 2B receptors work in concert to induce a strong protection against reperfusion injury in rat hearts. J Mol Cell Cardiol 2009, 47:684-690.
29. 2b receptor cascade. Cardiovasc Res 2006, 70:308-314.